Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients

J Hepatol. 1999 Jan;30(1):174. doi: 10.1016/s0168-8278(99)80025-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Female
  • Hepatorenal Syndrome / drug therapy*
  • Hepatorenal Syndrome / etiology*
  • Hormones / therapeutic use*
  • Humans
  • Liver Cirrhosis / complications*
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*

Substances

  • Hormones
  • Octreotide